Source: International Brazilian Journal of Urology. Unidade: FMRP
Subjects: NEOPLASIAS PROSTÁTICAS, COMORBIDADE
ABNT
MALUF, Fernando et al. Consensus on diagnosis and management of non-metastatic castration resistant prostate cancer in Brazil: focus on patient, selection, treatment efficacy, side effects and physician’s perception according to patient comorbidities. International Brazilian Journal of Urology, v. 47, n. 2, p. 359-373, 2021Tradução . . Disponível em: https://doi.org/10.1590/S1677-5538.IBJU.2020.0249. Acesso em: 07 fev. 2023.APA
Maluf, F., Soares, A., Avanço, G., Hada, A. L., Cardoso, A. P. G., Carneiro, A., et al. (2021). Consensus on diagnosis and management of non-metastatic castration resistant prostate cancer in Brazil: focus on patient, selection, treatment efficacy, side effects and physician’s perception according to patient comorbidities. International Brazilian Journal of Urology, 47( 2), 359-373. doi:10.1590/S1677-5538.IBJU.2020.0249NLM
Maluf F, Soares A, Avanço G, Hada AL, Cardoso APG, Carneiro A, Herchenhorn D, Jardim DLF, Schütz FAB, Kater FR, Reis RB dos. Consensus on diagnosis and management of non-metastatic castration resistant prostate cancer in Brazil: focus on patient, selection, treatment efficacy, side effects and physician’s perception according to patient comorbidities [Internet]. International Brazilian Journal of Urology. 2021 ; 47( 2): 359-373.[citado 2023 fev. 07 ] Available from: https://doi.org/10.1590/S1677-5538.IBJU.2020.0249Vancouver
Maluf F, Soares A, Avanço G, Hada AL, Cardoso APG, Carneiro A, Herchenhorn D, Jardim DLF, Schütz FAB, Kater FR, Reis RB dos. Consensus on diagnosis and management of non-metastatic castration resistant prostate cancer in Brazil: focus on patient, selection, treatment efficacy, side effects and physician’s perception according to patient comorbidities [Internet]. International Brazilian Journal of Urology. 2021 ; 47( 2): 359-373.[citado 2023 fev. 07 ] Available from: https://doi.org/10.1590/S1677-5538.IBJU.2020.0249